OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma

Overview of attention for article published in Frontiers in oncology, November 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (55th percentile)

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 2,649 followers.

OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma also see PMID: 29414764 https://t.co/bUkmXCXnQB

New article: OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma https://t.co/4PMIw8GLIe #breastcancer #oncology https://t.co/Um9tS5rrM8

New article: OXCT1 Enhances Gemcitabine Resistance Through NF-kappaB Pathway in Pancreatic Ductal Adenocarcinoma https://t.co/j3fX46TdnA #pancreaticcancer #oncology https://t.co/VALemZTmYd

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.